Approval · Notice of Compliance 17903 · 2016
ONSIOR: Notice of Compliance 17903
Issued March 21, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17903
- Date
- March 21, 2016
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ONSIOR | 02374722 | Marketed |
Medicinal ingredients
- ROBENACOXIB 40 MG per TAB